Table 2.
Characteristic | Total, n | Outpatient, n (%) | Hospital,a n (%) | Case management and screening, n (%) | Blood bank, n (%) | Other/unknown,b n (%) |
---|---|---|---|---|---|---|
Total | 8,913 | 4305 (48.3) | 1519 (17.0) | 1876 (21.1) | 411 (4.6) | 802 (9.0) |
Individual-level variables | ||||||
Race/Ethnicity | ||||||
Hispanic | 2,712 | 1,241 (45.8) | 299 (11.0) | 839 (30.9) | 82 (3.0) | 251 (9.3) |
Non-Hispanic Black | 3,898 | 1,842 (47.3) | 786 (20.2) | 668 (17.1) | 256 (6.6) | 346 (8.9) |
Non-Hispanic White | 2,303 | 1,222 (53.1) | 434 (18.8) | 369 (16.0) | 73 (3.2) | 205 (8.9) |
Sex at birth | ||||||
Female | 1,913 | 993 (51.9) | 434 (22.7) | 256 (13.4) | 79 (4.1) | 151 (7.9) |
Male | 7,000 | 3,312 (47.3) | 1,085 (15.5) | 1,620 (23.1) | 332 (4.7) | 651 (9.3) |
Age group at diagnosis | ||||||
13-19 years | 345 | 162 (47.0) | 43 (12.5) | 79 (22.9) | 42 (12.2) | 19 (5.5) |
20-39 years | 4,909 | 2,287 (46.6) | 637 (13.0) | 1,258 (25.6) | 263 (5.4) | 464 (9.5) |
40-59 years | 3,102 | 1,552 (50.0) | 672 (21.7) | 492 (15.9) | 101 (3.3) | 285 (9.2) |
60 years or older | 557 | 304 (54.6) | 167 (30.0) | 47 (8.4) | 5 (0.9) | 34 (6.1) |
US Birth | ||||||
Yesc | 5,743 | 2,831 (49.3) | 1,020 (17.8) | 1,049 (18.3) | 330 (5.8) | 513 (8.9) |
No | 3,170 | 1,474 (46.5) | 499 (15.7) | 827 (26.1) | 81 (2.6) | 289 (9.1) |
Mode of transmission | ||||||
Injection drug used | 465 | 173 (37.2) | 127 (27.3) | 93 (20.0) | 12 (2.6) | 60 (12.9) |
MSM | 5,113 | 2,547 (49.8) | 603 (11.8) | 1,352 (26.4) | 164 (3.2) | 447 (8.7) |
Heterosexual | 2,597 | 1,292 (49.8) | 563 (21.7) | 379 (14.6) | 133 (5.1) | 230 (8.9) |
Other/unknown | 738 | 293 (39.7) | 226 (30.6) | 52 (7.1) | 102 (13.8) | 65 (8.8) |
AIDS diagnosis within 3 months of HIV diagnosis | ||||||
Yes | 1,969 | 750 (38.1) | 856 (43.5) | 185 (9.4) | 12 (0.6) | 166 (8.4) |
No | 6,944 | 3,555 (51.2) | 663 (9.6) | 1,691 (24.4) | 399 (5.8) | 636 (9.2) |
Year HIV diagnosed | ||||||
2014 | 4,307 | 2,042 (47.4) | 734 (17.0) | 932 (21.6) | 200 (4.6) | 399 (9.3) |
2015 | 4,606 | 2,263 (49.1) | 785 (17.0) | 944 (20.5) | 211 (4.6) | 403 (8.8) |
ZCTA-level variables | ||||||
SES index, quartilesf | ||||||
1 (lowest SES) | 3,588 | 1,579 (44.0) | 638 (17.8) | 826 (23.0) | 214 (6.0) | 331 (9.2) |
2 | 2,277 | 1,137 (49.9) | 409 (18.0) | 431 (18.9) | 101 (4.4) | 199 (8.7) |
3 | 1,922 | 1,002 (52.1) | 285 (14.8) | 399 (20.8) | 58 (3.0) | 178 (9.3) |
4 (highest SES) | 1,126 | 587 (52.1) | 187 (16.6) | 220 (19.5) | 38 (3.4) | 94 (8.4) |
Non-Hispanic black density (% of total population) | ||||||
<25% | 5,308 | 2,660 (50.1) | 862 (16.2) | 1,148 (21.6) | 180 (3.4) | 458 (8.6) |
25-49% | 1,762 | 858 (48.7) | 300 (17.0) | 324 (18.4) | 102 (5.8) | 178 (10.1) |
≥ 50% | 1,843 | 787 (42.7) | 357 (19.4) | 404 (21.9) | 129 (7.0) | 166 (9.0) |
RUCA classification | ||||||
Urban | 8,685 | 4,182 (48.2) | 1,468 (16.9) | 1,852 (21.3) | 400 (4.6) | 783 (9.0) |
Rural | 228 | 123 (54.0) | 51 (22.4) | 24 (10.5) | 11 (4.8) | 19 (8.3) |
Abbreviations: AIDS: acquired immune deficiency syndrome; HIV: human immunodeficiency virus; MSM: male-to-male sexual contact; RUCA: rural-urban commuting area; SES: socioeconomic status; US: United States; ZCTA: ZIP code tabulation area.
Note: All p-values were < 0.001 except for year HIV diagnosed (p = .1068) and RUCA classification (p = .0013). P-value for individual-level variables calculated with Cochran-Mantel-Haenszel chi-square test controlling for ZCTA. p-value for neighborhood-level variables calculated with chi-square test.
Hospital includes any hospital department (e.g. inpatient, emergency department)
Other/unknown screening site includes laboratory, drug treatment center, other, and missing.
Category includes cases born in any of the 50 US states, District of Columbia, or any US dependency.
Includes cases with mode of transmission reported as injection drug use or injection drug use with male-to-male sexual contact.
Quartiles of standardized SES scores among Florida ZCTAs.